Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
0VZuL7sKgBwbdpad